CurrentUnitedHealthcarePolicy CS361NE.F

Lower Extremity Prosthetics (for Nebraska Only)

This policy governs medical necessity and coverage of lower extremity prosthetic devices for members in the State of Nebraska, including coding references and specific devices considered unproven.

Policy Summary

PayerUnitedHealthcare

PolicyLower Extremity Prosthetics (for Nebraska Only)

Policy CodePolicy CS361NE.F

Change TypeSupporting information/evidence and references updated

Effective DateMarch 1, 2026

Next Review Date

Key ActionFollow InterQual® CP: Durable Medical Equipment, Prosthetics, Lower Extremity criteria for medical necessity and prior authorization.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

Nebraskastate-specific

CS361NE.Fpolicy id

InterQual CPexternal criteria

85%+OPRA revision risk

n smallsmall studies noted

03/01/2026

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage and Medical Necessity Criteria

Medical Necessity and Unproven Devices

Covered when ALL of the InterQual Durable Medical Equipment, Prosthetics, Lower Extremity criteria are met; specific unproven devices are listed below.

General medical necessity: Device is medically necessary when member meets InterQual CP: Durable Medical Equipment, Prosthetics, Lower Extremity clinical criteria.see InterQual

Refer to InterQual for specific clinical entry and continuation criteria

Devices considered unproven and not medically necessary: The following are unproven and not medically necessary due to insufficient evidence of efficacy: bone-anchored percutaneous limb prosthesis (e.g., OPRA Implant System); endoskeletal knee-shin system with microprocessor control feature (swing/stance phase) for amputees with K1 or K2 functional classification who have transfemoral amputation (including knee disarticulation) or hip disarticulation/hemipelvectomy; combined microprocessor-controlled ankle-foot system with power assist for transfemoral, transtibial, or hip disarticulation/hemipelvectomy.insufficient evidence of efficacy

Specific device and patient functional level restrictions are enumerated in policy

Bone-anchored (osseointegrated) prostheses — evidence summary

Evidence summaries and clinical context

Bone-anchored prostheses evidence: Available evidence (systematic reviews and cohort/series studies summarized by Hayes and ECRI) is limited and low quality, reporting high rates of infection and mechanical complications and very high revision rates (above 85% in some long-term studies), leaving effectiveness and safety uncertain.

Hayes and ECRI reviews found insufficient or inconclusive support for OPRA in transfemoral amputees; see long-term follow-up data and complication rates in cited studies.

Microprocessor-controlled knees (MPKs) — evidence summary

Efficacy evidence for microprocessor-controlled knees

MPK efficacy for K3 ambulators: There is substantial literature supporting microprocessor-controlled knees (MPKs) for community ambulators (MFCL/K3), including randomized trials and comparative studies showing reductions in stumbles and improvements in patient-reported mobility, balance confidence, and ADL performance in selected populations.

Trials include Genium/Genium X3 RCT (n=26) and a pilot RCT in early rehabilitation (n=18, 15 completers) with enrollment weight <125 kg.

Evidence-based considerations for MPK coverage

Evidence indicates potential clinical benefits for MPKs in selected populations; studies recommend individualized assessment and trial fittings.

MPK benefits summary: For selected transfemoral amputees, particularly limited community ambulators (MFCL/K2) and community ambulators (K3+), MPKs are associated with reduced falls, improved balance confidence, and improvements in some performance measures versus non-MPKs.

Supported by systematic reviews and multiple trials but tempered by small sample sizes and heterogeneity.

Evidence limitations: Many studies are small, nonrandomized or pilot in design, have short follow-up, potential bias (lack of blinding, recall bias), and limited generalizability, constraining broad coverage conclusions.

Noted across systematic reviews and trial reports.

Trial fitting recommendation: Trial fittings are suggested to determine individual benefit from MPKs, particularly for MFCL-2 patients, because individual responses vary across MPK designs.

Trial fitting is recommended in systematic reviews and trial reports to personalize device selection.

Coverage considerations for powered hips and ankles

Evidence for powered microprocessor ankles and powered hips is limited and evolving.

Powered hip prosthesis (PHP): Prototype powered hip prostheses demonstrate feasibility in mechanical and limited functional testing (able-bodied simulator, small samples), but further development and human clinical testing are needed before conclusions on safety and effectiveness can be drawn.

Single small functional tests and mechanical ISO testing reported; additional optimization and evaluation required.

Powered/variable-stiffness ankles (MPAs/VSA): Small comparative studies report biomechanical benefits (increased prosthetic-side energy return and peak power; reduced contralateral loading) for variable-stiffness or powered ankles, but studies are limited by very small sample sizes, short follow-up, and methodological limitations; evidence reviews (Hayes, ECRI) report minimal or inconclusive support for routine clinical use.

Hayes evolving evidence review found minimal support; individual studies uncontrolled or underpowered.

Evidence and Guideline Summary (no explicit coverage criteria)

No explicit coverage decision language or medical necessity criteria are present in these summaries. The document provides evidence, guideline recommendations, and regulatory context.

evidence_summary: Multiple small randomized and observational studies report mixed clinical outcomes for powered microprocessor ankle-foot devices (biomechanical improvements in some studies; mixed patient-reported outcomes and metabolic effects), with overall limited generalizability.

See studies and reviews summarized in chunks 52–61 for details.

guideline_recommendations: VA/DoD Clinical Practice Guideline (2017, updated 2025) recommends use of validated functional outcome measures and suggests microprocessor knee units over non-microprocessor knees to reduce falls and optimize mobility; the guideline suggests osseointegration as an option for transfemoral amputees but does not make strong recommendations for powered ankle devices.

Guideline statements summarized in chunk 62.

regulatory_info: Prosthetic components are FDA Class I devices; the OPRA Implant System has received FDA premarket approval (PMA).

A bone-anchored percutaneous limb prosthesis (for example, the OPRA Implant System) is designated as unproven and not medically necessary. The policy states that available evidence is insufficient to establish efficacy for these devices and therefore they are excluded from coverage under this policy.

Systematic reviews and evidence assessments (Hayes; ECRI) conclude that the clinical literature on OPRA and similar osseointegrated, bone-anchored prostheses is limited and of low quality. Reports describe high rates of infection and mechanical complications, very high revision rates in some long-term cohorts (reported >85% in some studies with 10–15 year follow-up), and methodological weaknesses across available studies; taken together, these reviews judge the evidence for OPRA in transfemoral amputees as insufficient or inconclusive.

Reviews and individual studies found insufficient evidence to demonstrate the clinical benefit of powered microprocessor prosthetic ankles (MPAs/PwrAF) for transtibial (below‑knee) amputations. Existing studies are few, small, and of limited quality; Hayes concluded minimal or unclear support and did not identify robust systematic reviews or guideline endorsements to support routine coverage.

Key limitations across the evidence base include small sample sizes, heterogenous and often uncontrolled study designs, potential recall and selection bias, and limited duration of follow-up. These methodological constraints reduce generalizability and make it difficult to draw firm conclusions about safety and effectiveness for many novel prosthetic technologies.

An endoskeletal knee-shin system with a microprocessor control feature (swing and stance phase) is specified as not medically necessary when used for amputees with a functional classification of K1 or K2 who have a transfemoral amputation, knee disarticulation, hip disarticulation, or hemipelvectomy, due to insufficient evidence of efficacy in these lower‑functional‑level populations.

Because evidence reviews report limited, low‑quality data and document substantial complication and revision rates with OPRA and similar bone‑anchored systems, these devices may be considered investigational or not medically necessary in the absence of stronger safety and effectiveness data. The high infection and mechanical complication rates cited in long‑term studies are a principal concern for coverage decisions.

Powered microprocessor prosthetic ankles (MPAs/PwrAF) lack consistent, high‑quality clinical trial evidence demonstrating meaningful functional or patient‑reported benefits for transtibial amputees. Small uncontrolled studies and survey reports show mixed results and are vulnerable to bias; systematic evidence reviews have concluded the evidence is insufficient to support routine clinical use.

Applicable Codes and Functional Classifications

Applicable HCPCS L-codes (part 1)HCPCS

L5000	Partial foot, shoe insert with longitudinal arch, toe filler.
L5010	Partial foot, molded socket, ankle height, with toe filler.
L5020	Partial foot, molded socket, tibial tubercle height, with toe filler.
L5050	Ankle, Symes, molded socket, SACH foot.
L5060	Ankle, Symes, metal frame, molded leather socket, articulated ankle/foot (SACH).
L5100	Below knee (BK), molded socket, shin, SACH foot.
L5105	Below knee (BK), plastic socket, joints and thigh lacer, SACH foot.
L5150	Knee disarticulation (or through knee), molded socket, external knee joints, shin, SACH foot.
L5160	Knee disarticulation (or through knee), molded socket, bent knee configuration, external knee joints, shin, SACH foot.
L5200	Above knee (AK), molded socket, single axis constant friction knee, shin, SACH foot.

1–10 of 15

1/2

Applicable HCPCS L-codes (part 2)HCPCS

L5280	Hemipelvectomy, Canadian type; molded socket, hip joint, single axis constant friction knee, shin, SACH foot.
L5301	Below knee (BK), molded socket, shin, SACH foot, endoskeletal system.
L5312	Knee disarticulation (or through knee), molded socket, single axis knee, pylon, SACH foot, endoskeletal system.
L5321	Above knee (AK), molded socket, open end, SACH foot, endoskeletal system, single axis knee.
L5331	Hip disarticulation, Canadian type, molded socket, endoskeletal system, hip joint, single axis knee, SACH foot.
L5341	Hemipelvectomy, Canadian type, molded socket, endoskeletal system, hip joint, single axis knee, SACH foot.
L5400	Immediate postsurgical or early fitting, application of initial rigid dressing, including fitting, alignment, suspension, and one cast change, below knee (BK).
L5410	Immediate postsurgical or early fitting, application of initial rigid dressing, including fitting, alignment and suspension, below knee (BK), each additional cast change and realignment.
L5420	Immediate postsurgical or early fitting, application of initial rigid dressing, including fitting, alignment and suspension and one cast change above knee (AK) or knee disarticulation.
L5430	Immediate postsurgical or early fitting, application of initial rigid dressing, including fitting, alignment and suspension, above knee (AK) or knee disarticulation, each additional cast change and realignment.

Applicable HCPCS L-codes (continued)HCPCS

L5450	Immediate postsurgical or early fitting, application of nonweight bearing rigid dressing, below knee (BK).
L5460	Immediate postsurgical or early fitting, application of nonweight bearing rigid dressing, above knee (AK).
L5500	Initial, below knee (BK) PTB type socket, nonalignable system, pylon, no cover, SACH foot, plaster socket, direct formed.
L5505	Initial, above knee (AK), knee disarticulation, ischial level socket, nonalignable system, pylon, no cover, SACH foot, plaster socket, direct formed.
L5510	Preparatory, below knee (BK) PTB type socket, nonalignable system, pylon, no cover, SACH foot, plaster socket, molded to model.
L5520	Preparatory, below knee (BK) PTB type socket, nonalignable system, pylon, no cover, SACH foot, thermoplastic or equal, direct formed.
L5530	Preparatory, below knee (BK) PTB type socket, nonalignable system, pylon, no cover, SACH foot, thermoplastic or equal, molded to model.
L5535	Preparatory, below knee (BK) PTB type socket, nonalignable system, no cover, SACH foot, prefabricated, adjustable open end socket.
L5540	Preparatory, below knee (BK) PTB type socket, nonalignable system, pylon, no cover, SACH foot, laminated socket, molded to model.
L5560	Preparatory, above knee (AK), knee disarticulation, ischial level socket, nonalignable system, pylon, no cover, SACH foot, plaster socket, molded to model.

1–10 of 64

1/7

Applicable HCPCS/L CodesHCPCS

L5716	Addition, exoskeletal knee-shin system, polycentric, mechanical stance phase lock.
L5718	Addition, exoskeletal knee-shin system, polycentric, friction swing and stance phase control.
L5722	Addition, exoskeletal knee-shin system, single axis, pneumatic swing, friction stance phase control.
L5724	Addition, exoskeletal knee-shin system, single axis, fluid swing phase control.
L5726	Addition, exoskeletal knee-shin system, single axis, external joints, fluid swing phase control.
L5728	Addition, exoskeletal knee-shin system, single axis, fluid swing and stance phase control.
L5780	Addition, exoskeletal knee-shin system, single axis, pneumatic/hydra pneumatic swing phase
L5785	Addition, exoskeletal system, below knee (BK), ultra-light material (titanium, carbon fiber or equal).
L5790	Addition, exoskeletal system, above knee (AK), ultra-light material (titanium, carbon fiber or equal).
L5795	Addition, exoskeletal system, hip disarticulation, ultra-light material (titanium, carbon fiber or equal).

1–10 of 78

1/8

K-level functional classification — K0–K4 definitions

K0No ability or potential to ambulate or transfer safely with or without assistance; prosthesis does not enhance quality of life or mobility.

K1Ability or potential to use prosthesis for transfers or ambulation on level surfaces at a fixed cadence; typical of limited and unlimited household ambulator.

K2Ability or potential for ambulation with ability to traverse low-level environmental barriers (curbs, stairs, uneven surfaces); typical of limited community ambulator.

K3Ability or potential for ambulation with variable cadence; typical community ambulator who can traverse most environmental barriers and may have vocational, therapeutic, or exercise activity demands.

K4Ability or potential for prosthetic ambulation that exceeds basic ambulation skills, exhibiting high impact, stress, or energy levels; typical of child, active adult, or athlete.

Prior Authorization, Documentation, and Provider Guidance

Prior Authorization

InterQual criteria required for medical necessity — reference to InterQual CP: Durable Medical Equipment, Prosthetics, Lower Extremity

InterQual CP criteria are required and referenced for medical necessity determinations for lower extremity prosthetics. Providers should consult the InterQual® CP: Durable Medical Equipment, Prosthetics, Lower Extremity when submitting claims or prior authorization requests to ensure the clinical criteria are met.

InterQual criteria may be used by UnitedHealthcare or third-party tools in coverage determinations.

Prior Authorization

Prior authorization expectation for listed L‑codes — submit clinical records and prior auth as applicable

Prior authorization is expected for the listed L‑codes (including microprocessor knee codes L5856–L5859 and relevant addition/replacement L‑codes). Submit a prior authorization request with the clinical record when required by the member’s plan.

Affected codes include, but are not limited to: L5716–L5999, L7367–L7368, L7600, L7700, L8400–L8480, L5856–L5859.
Submit clinical records and trial fitting documentation as applicable.

Clinical and Evidence Background

Lower extremity prostheses restore function after amputation, and medical necessity decisions under this policy reference the InterQual® CP: Durable Medical Equipment, Prosthetics, Lower Extremity criteria. Coverage determinations require that members meet InterQual criteria; specific exclusions and devices judged unproven (for example, bone‑anchored prostheses and certain microprocessor or powered components in specified patient groups) are listed separately in the policy.

Terms and Definitions

ADLs — Activities of Daily Living definition

DefinitionActivities of Daily Living (ADLs): Basic tasks such as bathing, grooming, dressing, toilet use, eating, and physical ambulation.

PurposeUsed to assess basic functional independence relevant to prosthetic benefit and rehabilitation outcomes.

ExamplesBathing, grooming, dressing, toileting, eating, ambulation.

IADLs — Instrumental Activities of Daily Living definition

DefinitionInstrumental Activities of Daily Living (IADLs): Higher-level tasks related to independent living such as shopping, transportation, meal preparation, housecleaning, managing finances, and managing medications.

PurposeReflects more complex cognitive and executive demands for independent community living and may inform prosthetic goals.

Policy Revision History

2026-03-01policy_updateLatest

Policy effective date updated and supporting information/evidence and references reviewed as part of the March 1, 2026 policy update for Nebraska (CS361NE.F).

Policy Summary

PayerUnitedHealthcare

PolicyLower Extremity Prosthetics (for Nebraska Only)

Policy CodePolicy CS361NE.F

Change TypeSupporting information/evidence and references updated

Effective DateMarch 1, 2026

Next Review Date

Key ActionFollow InterQual® CP: Durable Medical Equipment, Prosthetics, Lower Extremity criteria for medical necessity and prior authorization.

SourceLink

On This Page

Regulatory information provided for informational purposes (chunk 63).

Patient weight limit (inclusion in MPK pilot RCT) — reported weight cutoff

Reported weight cutoff< 125 kg (inclusion criterion for MPK pilot RCT).

Source study contextMorgan et al. (2024) pilot RCT enrolled adults with recent unilateral transfemoral amputation who weighed < 125 kg; 18 enrolled, 15 completed.

Implication for device trialsWeight limits were applied in early rehabilitation trials of MPKs to define eligibility and device feasibility.

Documentation Required

Trial fitting and K‑level documentation — literature suggests trial fitting to determine benefit from MPKs for limited ambulators

Document the patient’s MFCL/K‑level and evidence of a trial fitting when appropriate (for example, trial fitting of a microprocessor‑controlled knee for MFCL‑2 limited community ambulators) to demonstrate functional benefit and to support medical necessity.

Record baseline and post‑trial functional measures, patient preference, and any objective performance testing used during the trial fitting.
Clearly state the assessed MFCL/K‑level and rationale for selecting an MPK versus non‑MPK.

Prior Authorization

Confirm prior authorization per plan — UnitedHealthcare may use third‑party tools; verify plan‑specific requirements

Confirm prior authorization and any plan‑specific requirements before delivering equipment. UnitedHealthcare may use third‑party criteria (e.g., InterQual) and tools to assist in benefit administration; verify the member’s specific plan for prior authorization rules.

Verify plan-specific prior authorization phone/fax/portal requirements and medical necessity edits before billing.
Failure to obtain required prior authorization may result in denial or retrospective review.

Denial Risk

Risk from bone‑anchored prosthesis complications — high infection and mechanical complication rates may lead to denials

Bone‑anchored (osseointegrated) prostheses have high reported rates of infection, osteomyelitis, revisions and mechanical complications in available studies. Providers should document why socket‑suspended options were considered and why bone‑anchored prosthesis is clinically necessary if pursued.

Evidence shows high infection and revision rates for OPRA and other osseointegrated systems; cite study safety findings when submitting requests.
Consideration of socket‑suspended prosthesis prior to bone‑anchored systems is recommended given complication risk.

Note

Evidence limitations that could affect coverage — small samples, heterogeneity, lack of validated measures

Available evidence has limitations that may affect coverage decisions: small sample sizes, low or very low quality studies, heterogeneous populations, and use of unvalidated or nonstandard outcome measures. These limitations should be acknowledged in submissions and supported with the best available objective data.

Studies often have small N, are nonrandomized or single‑center, and may lack validated outcome instruments.
When possible, provide objective performance measures and validated patient‑reported outcomes to strengthen the request.

Note

Conflicts with plan terms and modification/rescission risk — coverage governed by federal/state/contract terms; UnitedHealthcare may modify policy

When there is a conflict between this policy and federal, state, or contractual benefit plan terms, the federal/state/contractual requirements govern. UnitedHealthcare reserves the right to modify, update, or rescind policies; always confirm the member’s current benefit terms before proceeding.

Reference the member’s plan contract and applicable laws when making coverage determinations.
UnitedHealthcare may modify policies and use third‑party tools; coverage is not guaranteed by policy alone.

Documentation Required

Required documentation — medical record must contain history, physical exam, and pertinent diagnostic test results supporting necessity

The patient’s medical record must fully support medical necessity. Required documentation includes relevant medical history, focused physical exam, imaging and diagnostic test results, rehabilitation progress notes, and clear justification for the chosen prosthetic components.

Legible documentation of history and examination, problem list, prior treatments and their outcomes.
Pertinent diagnostic test results (e.g., imaging, DEXA when applicable), and notes from prosthetist/therapist regarding fit and function.

Documentation Required

Suggested clinical documentation elements from studies — pre/post assessments, gait analysis, Q‑TFA/SF‑36, imaging, rehabilitation plans

Suggested clinical documentation elements from the literature strengthen prior authorization requests: pre‑ and post‑intervention validated PROs, gait analysis or timed walk tests, Q‑TFA or SF‑36 scores, imaging results, and a detailed rehabilitation plan with goals and timelines.

Provide baseline and follow‑up PROs (Q‑TFA, SF‑36, PEQ, ABC) and objective measures (6‑minute walk, timed up and go, ADAPT/ADL‑Q where used).
Include gait analysis, step counts if available, and detailed rehabilitation/physical therapy plans tied to functional goals.

Documentation Required

Typical clinical documentation observed in studies — validated PROs, functional scales, MFCL/K‑level, and stability assessments

Typical clinical documentation observed in published studies includes validated patient‑reported outcome measures, MFCL/K‑level classification, stability/fall history, objective performance tests, and notes on device selection and trial fitting outcomes. Include these elements to align clinical records with evidence used in reviews.

Document MFCL/K‑level, history of falls or stumbles, and functional limitations relevant to device choice.
Record specifics of device selection (e.g., MPK vs NMCPK) and rationale, trial fitting results, and patient preference.

Note

Coverage decision documentation — reference federal, state, or contractual benefit plan terms when making determinations

Coverage decisions must reference the member’s federal, state, or contractual benefit terms in addition to clinical criteria. When submitting requests or appeals, include the plan language or cite applicable coverage clauses if they differ from standard policy assumptions.

If plan benefits mandate or exclude specific devices, supply the contractual language to expedite determination.
Document any previous authorization decisions, denials, or appeals related to the member’s prosthetic care.

ExamplesShopping, transportation, meal preparation, housecleaning, managing finances, managing medications.

K-levels (K0–K4) — MFCL definitions and use

DefinitionMFCL / K-level: clinical classification (K0–K4) used to assess rehabilitation potential and determine prosthetic component suitability (K0=no ambulation potential; K4=high activity).

Use in studiesK-levels stratify participants (e.g., K2 limited community ambulator, K3 community ambulator) and inform device selection and trial-fittings.

Clinical implicationsMPKs have ample evidence for K3 ambulators; suitability for lower K-levels (K1–K2) is limited and requires individualized assessment or trial fittings.

Microprocessor Controlled Ankle Foot Prosthesis definition

DefinitionMicroprocessor Controlled Ankle Foot Prosthesis: Device able to actively change ankle angle and identify sloping gradients and stair ascent/descent using microprocessor control and sensors (example: Proprio Foot).

FunctionAdjusts ankle mechanics dynamically to adapt to slopes/stairs and varying walking conditions via sensors and microprocessor algorithms.

Clinical relevanceDesigned to improve push-off, energy return, and adaptation versus passive feet; evidence for clinical benefit is limited and evolving.

Microprocessor Controlled Lower Limb Prostheses definition

DefinitionMicroprocessor Controlled Lower Limb Prostheses: Prosthetic knees that use sensors and a microprocessor to vary resistance during swing and stance phases to improve gait dynamics, stumble recovery, and safety (examples: Otto-Bock C-Leg, Ossur RheoKnee).

MechanismProvides variable resistance and swing-rate adjustments to respond to cadence changes and enhance stumble recovery.

Intended benefitMay improve gait pattern, wearer confidence, stability, and safety compared with non-microprocessor knees in appropriate candidates.

Prosthesis — definition

DefinitionProsthesis: An artificial device used to replace all or part of a missing body part and intended to restore normal function.

Clinical contextFor lower limb amputees, prostheses aim to enable ambulation on level and uneven surfaces, stairs, ramps, and independent dressing and return to work with or without modification.

Common amputation levelsTranstibial (below knee, BK) and transfemoral (above knee, AK) are the most common lower limb amputation levels referenced.

OPRA/Osseointegrated Prostheses for the Rehabilitation of Amputees — definition

DefinitionOPRA/Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA): A bone-anchored percutaneous limb prosthesis system that integrates an implant fixture into bone and attaches an external prosthesis via an abutment for skeletally mature patients.

Evidence summaryAvailable evidence is limited and low quality with high rates of infection and mechanical complications and very high revision rates reported in long-term studies.

Policy implicationDue to insufficient and concerning safety data, OPRA is considered unproven/unsupported for routine use in transfemoral amputees in the cited reviews.

MPK (Microprocessor-controlled knee) — definition

DefinitionMPK (Microprocessor-controlled knee): A prosthetic knee with electronic sensors and a microprocessor that adjusts swing and/or stance phase control to improve stability, mobility, and stumble recovery.

EvidenceAmple literature supports MPK efficacy for K3 community ambulators; randomized trials and pilot RCTs show reductions in stumbles and improvements in mobility and ADL outcomes in some populations.

Use considerationsTrial fittings are recommended to determine individual benefit, particularly for limited community ambulators (K2).

MFCL / K-level — definition and usage

DefinitionMFCL / K-level: Medicare Functional Classification Level (K0–K4) used to stratify ambulatory potential and guide prosthetic component selection.

Role in decision-makingK-levels inform indications such as MPK suitability (stronger evidence for K3) and restrictions (e.g., devices not medically necessary for K1–K2 for some microprocessor features).

Common usage in studiesStudies and systematic reviews stratify subjects by K-level (e.g., K2 limited community ambulators, K3 community ambulators) and use K-level for enrollment and outcome interpretation.

Powered Hip Prosthesis (PHP) — definition

DefinitionPowered Hip Prosthesis (PHP): A microprocessor-controlled, motorized prosthetic hip joint designed to provide active hip power and improve gait mechanics.

Prototype findingsPrototype PHPs have demonstrated mechanical feasibility and supported level walking in simulator testing but require further development to reduce weight/size and optimize control systems.

Evidence statusCurrent evidence is limited to small prototype and simulator studies; further human testing is needed before routine clinical adoption.

MPA/PwrAF — Powered microprocessor prosthetic ankle definition

DefinitionMPA/PwrAF (Powered microprocessor prosthetic ankle): An ankle-foot prosthesis with microprocessor control and active or quasi-active components that modify stiffness or provide powered push-off to assist gait.

Observed biomechanical effectsSmall studies report increased prosthetic-side energy return, peak power, and reduced contralateral loading compared with passive devices in some conditions.

Evidence limitationsClinical outcome evidence is limited, mixed, and based on small samples; systematic reviews judge support as minimal or insufficient for routine coverage.